Brett A. Sandercock's Insider Trades & SAST Disclosures
Brett A. Sandercock's most recent trade in Resmed Inc. was a trade of 1,000 ResMed Common Stock done at an average price of $230.4 . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Brett A. Sandercock.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 230.36 per share. | 10 Mar 2025 | 1,000 | 90,864 (0%) | 0% | 230.4 | 230,360 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 238.98 per share. | 10 Feb 2025 | 1,000 | 91,864 (0%) | 0% | 239.0 | 238,980 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 244.23 per share. | 09 Dec 2024 | 1,000 | 93,864 (0%) | 0% | 244.2 | 244,230 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 249.00 per share. | 08 Nov 2024 | 1,000 | 94,864 (0%) | 0% | 249 | 249,000 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 233.47 per share. | 08 Oct 2024 | 1,000 | 95,812 (0%) | 0% | 233.5 | 233,470 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 246.42 per share. | 09 Sep 2024 | 1,000 | 96,812 (0%) | 0% | 246.4 | 246,420 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 7,915 | 96,971 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2024 | 841 | 97,812 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 212.16 per share. | 08 Aug 2024 | 1,000 | 89,056 (0%) | 0% | 212.2 | 212,160 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 194.35 per share. | 08 Jul 2024 | 1,000 | 90,056 (0%) | 0% | 194.4 | 194,350 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 209.81 per share. | 10 Jun 2024 | 1,000 | 91,056 (0%) | 0% | 209.8 | 209,810 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 211.37 per share. | 08 May 2024 | 13,000 | 92,056 (0%) | 0% | 211.4 | 2,747,810 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 101.64 per share. | 08 May 2024 | 12,000 | 105,056 (0%) | 0% | 101.6 | 1,219,680 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 12,000 | 10,883 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 152.62 per share. | 27 Nov 2023 | 3,000 | 92,962 (0%) | 0% | 152.6 | 457,860 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2023 | 4,972 | 95,915 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 233.13 per share. | 10 May 2023 | 12,574 | 90,942 (0%) | 0% | 233.1 | 2,931,395 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 232.05 per share. | 09 May 2023 | 3,426 | 103,516 (0%) | 0% | 232.0 | 795,000 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 215.22 per share. | 17 Feb 2023 | 10,000 | 106,880 (0%) | 0% | 215.2 | 2,152,196 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 215.00 per share. | 13 Feb 2023 | 4,000 | 116,880 (0%) | 0% | 215 | 860,000 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 14,577 | 120,880 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 212.02 per share. | 07 Nov 2022 | 4,000 | 106,303 (0%) | 0% | 212.0 | 848,068 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 3,847 | 110,273 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 240.66 per share. | 10 Aug 2022 | 2,500 | 106,426 (0%) | 0% | 240.7 | 601,650 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 10 Aug 2022 | 2,500 | 108,926 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2022 | 2,500 | 0 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 22 Jul 2022 | 7,500 | 106,426 (0%) | 0% | 235 | 1,762,500 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 22 Jul 2022 | 2,500 | 113,926 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 22 Jul 2022 | 2,500 | 108,926 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2022 | 2,500 | 2,500 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2022 | 2,500 | 5,000 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jul 2022 | 2,500 | 7,500 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 22 Jul 2022 | 2,500 | 111,426 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 11 Apr 2022 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2022 | 2,500 | 10,000 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 247.00 per share. | 11 Apr 2022 | 2,500 | 106,354 (0%) | 0% | 247 | 617,500 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 10 Mar 2022 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2022 | 2,500 | 12,500 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 241.29 per share. | 10 Mar 2022 | 2,500 | 106,354 (0%) | 0% | 241.3 | 603,225 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 10 Feb 2022 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 2,500 | 15,000 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 241.86 per share. | 10 Feb 2022 | 2,500 | 106,354 (0%) | 0% | 241.9 | 604,650 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jan 2022 | 2,500 | 17,500 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 10 Jan 2022 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 235.00 per share. | 10 Jan 2022 | 2,500 | 106,354 (0%) | 0% | 235 | 587,500 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 10 Dec 2021 | 2,500 | 108,854 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 2,500 | 20,000 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 264.92 per share. | 10 Dec 2021 | 2,500 | 106,354 (0%) | 0% | 264.9 | 662,300 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 254.81 per share. | 16 Nov 2021 | 20,360 | 105,193 (0%) | 0% | 254.8 | 5,187,932 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Nov 2021 | 1,161 | 106,354 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 10 Nov 2021 | 2,500 | 87,333 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2021 | 2,500 | 22,500 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 260.58 per share. | 10 Nov 2021 | 2,500 | 84,833 (0%) | 0% | 260.6 | 651,450 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 253.37 per share. | 11 Oct 2021 | 5,000 | 84,786 (0%) | 0% | 253.4 | 1,266,850 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 11 Oct 2021 | 2,500 | 89,786 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2021 | 2,500 | 25,000 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 297.33 per share. | 10 Sep 2021 | 5,000 | 87,286 (0%) | 0% | 297.3 | 1,486,650 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Sep 2021 | 2,500 | 27,500 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 10 Sep 2021 | 2,500 | 92,286 (0%) | 0% | 57.8 | 144,400 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 281.73 per share. | 20 Aug 2021 | 10,736 | 89,786 (0%) | 0% | 281.7 | 3,024,653 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 5,543 | 30,000 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 20 Aug 2021 | 5,543 | 100,522 (0%) | 0% | 57.8 | 320,164 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2021 | 5,193 | 35,543 | - | - | ResMed Common Stock Options | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.76 per share. | 20 Aug 2021 | 5,193 | 94,979 (0%) | 0% | 57.8 | 299,948 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 4,784 | 89,786 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 278.05 per share. | 10 Aug 2021 | 2,500 | 85,002 (0%) | 0% | 278.1 | 695,125 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 248.46 per share. | 12 Jul 2021 | 2,500 | 87,502 (0%) | 0% | 248.5 | 621,150 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 212.84 per share. | 10 Jun 2021 | 2,500 | 90,002 (0%) | 0% | 212.8 | 532,100 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 196.00 per share. | 10 May 2021 | 2,500 | 92,502 (0%) | 0% | 196 | 490,000 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 198.47 per share. | 12 Apr 2021 | 2,500 | 94,922 (0%) | 0% | 198.5 | 496,175 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 185.00 per share. | 10 Mar 2021 | 2,500 | 97,422 (0%) | 0% | 185 | 462,500 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 201.37 per share. | 10 Feb 2021 | 2,500 | 99,922 (0%) | 0% | 201.4 | 503,425 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2021 | 1,822 | 102,422 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 218.70 per share. | 11 Jan 2021 | 2,500 | 100,600 (0%) | 0% | 218.7 | 546,750 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 211.06 per share. | 10 Dec 2020 | 2,500 | 103,100 (0%) | 0% | 211.1 | 527,650 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 211.00 per share. | 24 Nov 2020 | 5,000 | 105,600 (0%) | 0% | 211 | 1,055,000 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 214.74 per share. | 17 Nov 2020 | 26,246 | 110,600 (0%) | 0% | 214.7 | 5,636,066 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 176.72 per share. | 15 Oct 2020 | 2,500 | 84,275 (0%) | 0% | 176.7 | 441,800 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 175.49 per share. | 15 Sep 2020 | 2,500 | 86,775 (0%) | 0% | 175.5 | 438,725 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 177.55 per share. | 17 Aug 2020 | 2,500 | 89,275 (0%) | 0% | 177.6 | 443,875 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2020 | 6,979 | 91,775 (0%) | 0% | 0 | ResMed Common Stock | |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 196.98 per share. | 15 Jul 2020 | 2,500 | 84,796 (0%) | 0% | 197.0 | 492,450 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 158.79 per share. | 15 Jun 2020 | 2,500 | 87,296 (0%) | 0% | 158.8 | 396,975 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 162.05 per share. | 15 May 2020 | 2,500 | 89,796 (0%) | 0% | 162.1 | 405,125 | ResMed Common Stock |
| Resmed Inc. | Brett A. Sandercock | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 159.03 per share. | 15 Apr 2020 | 2,500 | 92,211 (0%) | 0% | 159.0 | 397,575 | ResMed Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges